TAGline October 2023
We’re thrilled to share the 2023 edition of TAGline, which explores some of the barriers that obstruct research from being effectively implemented to improve people’s health.
TAG to Honor Leaders of Latino HIV Community, Pediatric Drug-Resistant TB, and Transgender Health at RIAA 2023
Our annual Research in Action Awards (RIAA) event is TAG’s biggest night of the year. On October 19, we’ll be deeply honored to gather with our most cherished supporters and community members to recognize just a few of the many visionaries whose work has brought us closer to ending HIV, TB, and HCV.
HCV Elimination Among People Living with and at Risk of HIV: Challenges and Opportunities
Following the White House’s recent proposal for a National Hepatitis C Elimination Plan as part of its Fiscal Year 2024 budget request to Congress, and the fact that key populations for HIV are also at high risk of HCV, Treatment Action Group is organizing a webinar that will highlight best practices and challenges for HCV elimination with a specific focus on high-burden populations.
Letter to Dr. Jeanne Marazzo, New Director NIAID
We're excited to welcome Dr. Jeanne Marazzo as the first woman and openly LGBTQ+ Director of the National Institute of Allergy and Infectious Diseases (NIAID).
TAG Mourns the Loss of Dr. Stephaun Elite Wallace
TAG extends our deepest condolences to the family, friends and loved ones of Dr. Stephaun Elite Wallace, PhD, MS. Dr. Wallace was a treasure to all who knew and worked with him, and his legacy of mentorship and community engagement in the HIV research landscape will be felt for generations.
2023 Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Broadly Neutralizing Antibodies (bNAbs) and HIV Cure-Related Research
HIV has evolved multiple mechanisms to evade inhibition by antibodies, which are Y-shaped immune system proteins that normally play a key role in fending off or controlling infections.
Open Letter: Urgent Action Necessary for Equitable Access to Bedaquiline in All Countries with High Burdens of TB, MDR-TB, and TB/HIV
TAG and 82 other organizations and 106 individuals representing TB-affected communities and civil society sent an open letter to Johnson & Johnson calling on the company...
2022 Annual Report
As we close another year of unprecedented challenges and achievements, I'm honored to share with you Treatment Action Group's (TAG) 2022 Annual Report.
Treatment Action Group Welcomes Moe Ari Brown as Newest Board Member
Treatment Action Group (TAG) is pleased to announce the election of Moe Ari Brown to our Board of Directors.